Trial phase of Illumina Next Generation Sequencing (NGS) also known as Venom Sequencing machine has begun in All India Institute of Medical Sciences (AIIMS) Raipur.

 

Testing facility is expected to begin by the end of January 2021. It is the first ever machine in state of Chhattisgarh.

Professor Nitin M Nagarkar, Director of AIIMS informed that Next Generation Sequencing machine has reached Lab of AIIMS.

 

At present it is in trial face and soon it would be used by the doctors for research and clinical purpose. It has been installed at Viral Research and Diagnostic Laboratory of AIIMS. At present same machine is present in VRD lab of Pune, where samples are sent for testing from all over the country. It is used for detection of all types of Cancer, Research purpose, to study molecular study of virus. Detection of second stream of Corona would be possible with the help of the machine. It will help the doctors in studying behavioral change of virus on different persons.

 

Dr Nagarkar further informed that NGS has rapidly become the state of the art for high-throughput genomic analyses. The robust technology provides access to numerous applications ranging from genomic sequencing, re-sequencing, whole-transcriptome analysis, small RNA, miRNA, non-coding RNA, targeted sequencing, Chip-seq and ATAC-seq. Ribonucleic acid (RNA) is an important biological macromolecule that is present in all biological cells. Using a massively parallel sequencing approach, NGS is capable of generating gigabases of high quality sequence, maximizing throughput while minimizing the cost and time to generate this data. The cost of machine is about Rs 1.25 Crores.

Dr Nagarkar informed that as per schedule the machine has arrived and has been started on trial face. VRD lab of AIIMS was